253 related articles for article (PubMed ID: 33053176)
1. Repurposing the anti-viral drug zidovudine (AZT) in combination with meropenem as an effective treatment for infections with multi-drug resistant, carbapenemase-producing strains of Klebsiella pneumoniae.
DeSarno AE; Parcell BJ; Coote PJ
Pathog Dis; 2020 Dec; 78(9):. PubMed ID: 33053176
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing
Zhang W; Guo Y; Li J; Zhang Y; Yang Y; Dong D; Zhu D; He P; Hu F
Antimicrob Resist Infect Control; 2018; 7():142. PubMed ID: 30479755
[TBL] [Abstract][Full Text] [Related]
3. Study of
Zhang W; Guo Y; Yang Y; Dong D; Zheng Y; Zhu D; Hu F
Microb Drug Resist; 2020 Mar; 26(3):204-210. PubMed ID: 31553260
[No Abstract] [Full Text] [Related]
4. Azidothymidine Produces Synergistic Activity in Combination with Colistin against Antibiotic-Resistant
Hu Y; Liu Y; Coates A
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373798
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of minocycline combined with aminoglycosides against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
Wentao N; Guobao L; Jin Z; Junchang C; Rui W; Zhancheng G; Youning L
J Antibiot (Tokyo); 2018 May; 71(5):506-513. PubMed ID: 29416121
[TBL] [Abstract][Full Text] [Related]
6. Captopril potentiated meropenem activity against MBL-producing carbapenem-resistant Klebsiella pneumoniae: in vitro and in vivo study.
Zhao D; Li H; Yue C; Sun K; Dai Y; Zhang H; Liu Y; Gao Y; Li J
J Inorg Biochem; 2021 May; 218():111381. PubMed ID: 33647540
[TBL] [Abstract][Full Text] [Related]
7. Time kill-assays of antibiotic combinations for multidrug resistant clinical isolates of OXA-48 carbapenemase producing Klebsiella pneumoniae.
Erdem F; Díez-Aguilar M; Oksuz L; Kayacan C; Abulaila A; Oncul O; Morosini MI; Cantón R; Aktas Z
Acta Microbiol Immunol Hung; 2022 Sep; 69(3):215-219. PubMed ID: 35895557
[TBL] [Abstract][Full Text] [Related]
8.
Hagiya H; Aoki K; Akeda Y; Yamamoto N; Shanmugakani RK; Ishii Y; Tomono K
Microb Drug Resist; 2019; 25(6):839-845. PubMed ID: 30835635
[No Abstract] [Full Text] [Related]
9. Antibacterial activity and carbapenem re-sensitizing ability of 1,10-phenanthroline-5,6-dione and its metal complexes against KPC-producing Klebsiella pneumoniae clinical strains.
Vianez Peregrino I; Ferreira Ventura R; Borghi M; Pinto Schuenck R; Devereux M; McCann M; Souza Dos Santos AL; FerreiraNunes AP
Lett Appl Microbiol; 2021 Aug; 73(2):139-148. PubMed ID: 33843058
[TBL] [Abstract][Full Text] [Related]
10. Effect of the meropenem MIC on the killing activity of meropenem and polymyxin B in combination against KPC-producing Klebsiella pneumoniae.
Kulengowski B; Campion JJ; Feola DJ; Burgess DS
J Antibiot (Tokyo); 2017 Aug; 70(9):974-978. PubMed ID: 28676713
[No Abstract] [Full Text] [Related]
11. Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments.
Tängdén T; Hickman RA; Forsberg P; Lagerbäck P; Giske CG; Cars O
Antimicrob Agents Chemother; 2014; 58(3):1757-62. PubMed ID: 24395223
[TBL] [Abstract][Full Text] [Related]
12. Investigation of in vitro efficacy of quercetin-meropenem combination in carbapenemase-producing Klebsiella pneumoniae isolates.
Aydemir Ö; Ormanoğlu G; Ayhancı T; Zengin M; Köroğlu M
J Infect Dev Ctries; 2023 Sep; 17(9):1325-1329. PubMed ID: 37824360
[TBL] [Abstract][Full Text] [Related]
13. Novel Polymyxin Combination with the Antiretroviral Zidovudine Exerts Synergistic Killing against NDM-Producing Multidrug-Resistant Klebsiella pneumoniae.
Lin YW; Abdul Rahim N; Zhao J; Han ML; Yu HH; Wickremasinghe H; Chen K; Wang J; Paterson DL; Zhu Y; Rao GG; Zhou QT; Forrest A; Velkov T; Li J
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670431
[TBL] [Abstract][Full Text] [Related]
14. In vitro synergistic activity of fosfomycin in combination with meropenem, amikacin and colistin against OXA-48 and/or NDM-producing
Erturk Sengel B; Altinkanat Gelmez G; Soyletir G; Korten V
J Chemother; 2020 Sep; 32(5):237-243. PubMed ID: 32228228
[No Abstract] [Full Text] [Related]
15. Population Pharmacokinetics of High-Dose Continuous-Infusion Meropenem and Considerations for Use in the Treatment of Infections Due to KPC-Producing Klebsiella pneumoniae.
Cojutti P; Sartor A; Righi E; Scarparo C; Bassetti M; Pea F
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760900
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of meropenem heteroresistance in Klebsiella pneumoniae carbapenemase (KPC)-producing clinical isolates of K. pneumoniae.
Pournaras S; Kristo I; Vrioni G; Ikonomidis A; Poulou A; Petropoulou D; Tsakris A
J Clin Microbiol; 2010 Jul; 48(7):2601-4. PubMed ID: 20504985
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic, molecular, and in silico characterization of coumarin as carbapenemase inhibitor to fight carbapenem-resistant Klebsiella pneumoniae.
Abdel-Halim MS; El-Ganiny AM; Mansour B; Yahya G; Latif HKAE; Askoura M
BMC Microbiol; 2024 Feb; 24(1):67. PubMed ID: 38413891
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of generic meropenem products in combination with colistin in carbapenemase-producing Klebsiella pneumoniae experimental osteomyelitis.
Tattevin P; Dinh A; Ghout I; Mouton W; Verdier MC; Laurent F; Lemaitre F; Gatin L; Saleh-Mghir A; Crémieux AC
Int J Antimicrob Agents; 2020 Nov; 56(5):106152. PubMed ID: 32898684
[TBL] [Abstract][Full Text] [Related]
19. Klebsiella pneumoniae carbapenemase (KPC) in urinary infection isolates.
Bedenić B; Sardelić S; Bogdanić M; Zarfel G; Beader N; Šuto S; Krilanović M; Vraneš J
Arch Microbiol; 2021 May; 203(4):1825-1831. PubMed ID: 33507339
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of double carbapenem and colistin combinations against OXA-48, NDM carbapenemase-producing colistin-resistant Klebsiella pneumoniae strains.
Erdem F; Abulaila A; Aktas Z; Oncul O
Antimicrob Resist Infect Control; 2020 May; 9(1):70. PubMed ID: 32430058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
